Is a complete ANTX research report available?

No complete published report is available for AN2 Therapeutics, Inc. (ANTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AN2 Therapeutics, Inc. (ANTX)

NASDAQ: ANTX · USD

$4.92

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ANTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	177.2M
Net income (ttm)	-34.6M
EPS (ttm)	-$1.11
Shares out	36M
Volume	128,469
Beta	-0.99
Price target	$9.00	+82.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -34.6M
EPS (ttm): -$1.11
Market cap: 177.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ANTX indicators

Market & fundamental data

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001880438
Company name	AN2 Therapeutics, Inc.
Country	United States
Country code	US
Cusip	037326105
Employees	21
Employees Change	-1%
Employees Change Percent	-4.55
Enterprise value	$95.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2022-03-25
Isin	US0373261058
Last refreshed	2026-07-25
Market cap	$177.2M
Market cap category	Micro-Cap
Price	$4.92
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	ANTX
Website	https://www.an2therapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.11%
P/B ratio	2.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-34.6M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Profit Per Employee	$-1.6M
ROA	-27.48
Roa5y	-33.36
ROCE	-45.31
ROE	-44.56
Roe5y	-55.88
ROIC	-29.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	332.01%
Cagr3y	-14.27%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$87.5M
Cash	$85.3M
Current Assets	$87.5M
Current Liabilities	$5.6M
Debt	$0
Equity	$81.8M
Liabilities	$5.7M
Long Term Assets	$0
Long Term Liabilities	$170,000
Net Cash	$85.3M
Net Cash By Market Cap	$47.17
Net Cash Growth	27.18%
Net Debt Equity	$-1.04
Tangible Book Value	$81.8M
Tangible Book Value Per Share	$2.27
WACC	-1.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.73
Net Working Capital	$-3.4M
Quick ratio	15.51
Working Capital	$81.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	331.58%
200-day SMA	2.71
3Y total return	-37%
50-day SMA	4.63
50-day SMA vs 200-day SMA	50over200
All Time High	23.58
All Time High Change	-79.13%
All Time High Date	2022-05-16
All Time Low	0.87
All Time Low Change	465.52%
All Time Low Date	2024-08-09
ATR	0.39
Beta	-0.99
Beta1y	-2.44
Beta2y	-0.17
Ch YTD	331.6
High	5.16
High52	6.91
High52 Date	2026-03-09
High52ch	-28.8%
Low	4.77
Low52	1
Low52 Date	2026-02-19
Low52ch	392%
Ma50ch	6.31%
Price vs 200-day SMA	81.75%
RSI	56.49
RSI Monthly	55.62
RSI Weekly	62.4
Sharpe ratio	1.59x
Sortino ratio	5.02
Total Return	-4.4%
Tr YTD	331.6
Tr1m	-1.2%
Tr1w	5.13%
Tr3m	14.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.23
Operating Income	$-37.1M
Price target	$9
Price Target Change	$82.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,979,526%
Float Percent	55.47%
Shares Insiders	6.14%
Shares Institutions	44.69%
Shares Out	36,016,161
Shares Qo Q	12.2%
Shares Yo Y	4.4%
Short Float	9.63%
Short Ratio	4.52
Short Shares	5.34

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	386,859.05x
Bv Per Share	2.27
Ch1m	-1.2
Ch1w	5.13
Ch1y	331.6
Ch3m	14.95
Ch3y	-37
Ch6m	320.5
Change	0%
Change From Open	0.2
Close	4.92
Days Gap	-0.2
Dollar Volume	632,067.5
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-37.1M
EBITDA	$-37.1M
EPS	$-1.11
F Score	2
Financing CF	37,377,000
Fiscal Year End	December
Founded	2,017
Investing CF	27,408,000
Ipr	-66.53
Iprfo	-70.21
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-17
Ma150	3.22
Ma150ch	52.8%
Ma20	4.72
Ma20ch	4.35%
Net CF	33,502,000
Next Earnings Date	2026-08-11
Open	4.91
Optionable	No
Position In Range	38.46
Price Date	2026-07-24
Ptbv Ratio	2.21
Relative Volume	0.33x
Share Based Comp	5,659,000
Tr6m	320.51%
Us State	California
Volume	128,469

AN2 Therapeutics, Inc. (ANTX)

Coverage state: Market snapshot only — no published research

Generate the first ANTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ANTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ANTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ANTX

Frequently asked questions